Your browser doesn't support javascript.
loading
Development and validation of a 25-Gene Panel urine test for prostate cancer diagnosis and potential treatment follow-up.
Johnson, Heather; Guo, Jinan; Zhang, Xuhui; Zhang, Heqiu; Simoulis, Athanasios; Wu, Alan H B; Xia, Taolin; Li, Fei; Tan, Wanlong; Johnson, Allan; Dizeyi, Nishtman; Abrahamsson, Per-Anders; Kenner, Lukas; Feng, Xiaoyan; Zou, Chang; Xiao, Kefeng; Persson, Jenny L; Chen, Lingwu.
Afiliação
  • Johnson H; Olympia Diagnostics, Inc., Sunnyvale, CA, USA.
  • Guo J; Department of Urology, The Second Clinical Medical College of Jinan University, Shenzhen People's Hospital, Shenzhen Urology Minimally Invasive Engineering Centre, Shenzhen, China.
  • Zhang X; Shenzhen Public Service Platform on Tumor Precision Medicine and Molecular Diagnosis, Clinical Medical Research Centre, The Second Clinical College of Jinan University, Shenzhen People's Hospital, Shenzhen, China.
  • Zhang H; Department of Bio-diagnosis, Institute of Basic Medical Sciences, Beijing, China.
  • Simoulis A; Department of Bio-diagnosis, Institute of Basic Medical Sciences, Beijing, China.
  • Wu AHB; Department of Clinical Pathology and Cytology, Skåne University Hospital, Malmö, Sweden.
  • Xia T; Clinical Laboratories, San Francisco General Hospital, San Francisco, CA, USA.
  • Li F; Department of Urology, Foshan First People's Hospital, Foshan, China.
  • Tan W; Department of Urology, Nanfang Hospital, Southern Medical University, Guangzhou, China.
  • Johnson A; Department of Urology, Nanfang Hospital, Southern Medical University, Guangzhou, China.
  • Dizeyi N; Kinetic Reality, Santa Clara, CA, USA.
  • Abrahamsson PA; Department of Translational Medicine, Lund University, Clinical Research Centre, Malmö, Sweden.
  • Kenner L; Department of Translational Medicine, Lund University, Clinical Research Centre, Malmö, Sweden.
  • Feng X; Department of Experimental Pathology, Medical University Vienna & Unit of Laboratory Animal Pathology, University of Veterinary Medicine, Vienna, Austria.
  • Zou C; Department of Bio-diagnosis, Institute of Basic Medical Sciences, Beijing, China.
  • Xiao K; Shenzhen Public Service Platform on Tumor Precision Medicine and Molecular Diagnosis, Clinical Medical Research Centre, The Second Clinical College of Jinan University, Shenzhen People's Hospital, Shenzhen, China.
  • Persson JL; Department of Urology, The Second Clinical Medical College of Jinan University, Shenzhen People's Hospital, Shenzhen Urology Minimally Invasive Engineering Centre, Shenzhen, China.
  • Chen L; Shenzhen Public Service Platform on Tumor Precision Medicine and Molecular Diagnosis, Clinical Medical Research Centre, The Second Clinical College of Jinan University, Shenzhen People's Hospital, Shenzhen, China.
BMC Med ; 18(1): 376, 2020 12 01.
Article em En | MEDLINE | ID: mdl-33256740

Texto completo: 1 Coleções: 01-internacional Temas: Geral / Tipos_de_cancer / Prostata Base de dados: MEDLINE Assunto principal: Neoplasias da Próstata / Biomarcadores Tumorais / Antígeno Prostático Específico / Detecção Precoce de Câncer Tipo de estudo: Diagnostic_studies / Observational_studies / Prognostic_studies / Risk_factors_studies / Screening_studies Limite: Adult / Aged / Aged80 / Humans / Male / Middle aged Idioma: En Revista: BMC Med Assunto da revista: MEDICINA Ano de publicação: 2020 Tipo de documento: Article País de afiliação: Estados Unidos

Texto completo: 1 Coleções: 01-internacional Temas: Geral / Tipos_de_cancer / Prostata Base de dados: MEDLINE Assunto principal: Neoplasias da Próstata / Biomarcadores Tumorais / Antígeno Prostático Específico / Detecção Precoce de Câncer Tipo de estudo: Diagnostic_studies / Observational_studies / Prognostic_studies / Risk_factors_studies / Screening_studies Limite: Adult / Aged / Aged80 / Humans / Male / Middle aged Idioma: En Revista: BMC Med Assunto da revista: MEDICINA Ano de publicação: 2020 Tipo de documento: Article País de afiliação: Estados Unidos